Navigation Links
Depression Taking Toll on Returning U.S. Vets
Date:8/18/2007

he soldier's experiences once they return," said Deborah Gibbs, a senior analyst for the Children and Families Program at RTI International, in Research Triangle Park, N.C.

Gibbs led a study, published in July in the Journal of the American Medical Association, that found the children of soldiers who saw combat in Iraq were at heightened risk of abuse or neglect when their parent returned home.

In the new study, Sayers' team examined the home life of U.S. soldiers returning from service in either Iraq or Afghanistan. The soldiers had not suffered any grievous physical injury, but routine psychiatric evaluations, conducted upon their return, turned up signs of depression, PTSD or other mental woes.

About 40 percent of the veterans were either married or cohabiting with a partner, 21 percent were recently separated or divorced, and about half had at least one child.

Sayers stressed that the groups studied "are not representative of returning vets as a whole," but are a subset diagnosed with mental health symptoms after deployment. Those types of troubles aren't rare, however: One 2006 study found that one-third of U.S. soldiers returning from Iraq and Afghanistan are availing themselves of mental health services. And a government report released Thursday found there were 99 confirmed suicides among U.S. Army soldiers in 2006, the highest rate in 26 years. More than 25 percent of those who committed suicide did so while serving in Iraq and Afghanistan.

In the new study, a diagnosis of either major or minor depression, or PTSD, was highly correlated with family problems, the researchers found.

Those troubles included physical or mental abuse. For example, 56 percent of soldiers with current or recently separated partners reported severe conflicts with partners resulting in "shouting, pushing or shoving," and 35 percent felt their partner was now fearful of them.

Two-thirds of married or co-ha
'/>"/>


Copyright©2007 ScoutNews,LLC.

Page: 1 2 3 4

Related medicine news :

1. Low Cholesterol Linked to Severe Depression and Violent Behavior in Men
2. Depression may cause delayed wound healing
3. Diabetes and Depression often go hand-in-hand
4. Depression and heart failure
5. Depression disturbs heart rate
6. Depression a possible danger in elderly
7. Mild Depression may guard aged women
8. Treating Depression In Children Could Lead To Poor Bone Development
9. New treatment for depression
10. Depression linked to mortality
11. Depression increases heart attacks
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:You Never Get a Second Chance to Make a First Impression: High-Definition for the Web 2Health News:Moravia Worldwide to Present Live Webinar on Creation and Use of Terminology in Localization 2Health News:Moravia Worldwide to Present Live Webinar on Creation and Use of Terminology in Localization 3Health News:Lung Cancer Alliance Praises Growing National Coalition 2Health News:Lung Cancer Alliance Praises Growing National Coalition 3Health News:Book Offers Help for Parents Struggling with Difficult Teens During the Upcoming Holidays 2Health News:Securities Class Action Filed by Shepherd, Finkelman, Miller & Shah, LLP on Behalf of Hemispherx Biopharma Securities Purchasers Between February 18, 2009 and November 2, 2009 2Health News:Securities Class Action Filed by Shepherd, Finkelman, Miller & Shah, LLP on Behalf of Hemispherx Biopharma Securities Purchasers Between February 18, 2009 and November 2, 2009 3Health News:Securities Class Action Filed by Shepherd, Finkelman, Miller & Shah, LLP on Behalf of Hemispherx Biopharma Securities Purchasers Between February 18, 2009 and November 2, 2009 4
Breaking Medicine Technology:Free Wheelchair Mission Breaks List of Top 60 OC Nonprofits in 2009 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 4Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 5Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 6Biomatrica Launches DNAgard(TM) for Room Temperature Storage of Tissues and Cell Culture 2Biomatrica Launches DNAgard(TM) for Room Temperature Storage of Tissues and Cell Culture 3New H1N1 Flu Guide Offers Practical Tools and Tips for HR Professionals 61032 1New H1N1 Flu Guide Offers Practical Tools and Tips for HR Professionals 61032 2New H1N1 Flu Guide Offers Practical Tools and Tips for HR Professionals 61032 3Lung Cancer Alliance Staff and Advocates to Ring Closing Bell of New York Stock Exchange 28TM 29 61028 1Lung Cancer Alliance Staff and Advocates to Ring Closing Bell of New York Stock Exchange 28TM 29 61028 2PIA Says Inclusion of Agents in House Healthcare Bill is Positive But Concerns Remain 61024 1PIA Says Inclusion of Agents in House Healthcare Bill is Positive But Concerns Remain 61024 2PIA Says Inclusion of Agents in House Healthcare Bill is Positive But Concerns Remain 61024 3
Other Medicine Technology:MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 2MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 3MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 4MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 5MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 6MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 7MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 8MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 9MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 10IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial 2IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial 3IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial 4IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial 5